Clinical Trials for Effectiveness of Combination Therapy using Ezetimibe and Rosuvastatin/Atorvastatin

Trial Profile

Clinical Trials for Effectiveness of Combination Therapy using Ezetimibe and Rosuvastatin/Atorvastatin

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Mar 2011

At a glance

  • Drugs Ezetimibe (Primary) ; Atorvastatin; Rosuvastatin
  • Indications Coronary artery disease; Hyperlipidaemia
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms CTE2RA
  • Most Recent Events

    • 10 Mar 2011 Status changed from active, no longer recruiting to completed.
    • 10 Dec 2010 Planned End Date changed from 1 Sep 2010 to 1 Jan 2011 as reported by University Hospital Medical Information Network - Japan record.
    • 10 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top